Polymeric excipients are essential to controlled drug release in LAIs, yet excipient selection remains complex. In this February 10th webinar, USP experts outline an integrated framework for LG polymer naming and characterization, review current USP standards, and share emerging tools designed to support quality, consistency, and regulatory confidence.
Sentry BioPharma Services, Inc. (Sentry US) protects product SISPQ by offering compliant pharmaceutical services, including cGMP temperature-controlled storage, controlled substance management (CS III-V), clinical/commercial labeling and secondary packaging. Sentry also provides import/export optimization by leveraging our end-to-end GxP logistics, global distribution and Foreign Trade Zone expertise. Sentry’s status as a US Foreign Trade Zone enables products from outside the United States to be received and held within cGMP storage, pending approval for importation from the FDA, CBP and DEA. Sentry is VAWD accredited, licensed in all US states and inspected by the FDA, along with numerous international authorities. Sentry’s newest facility in Columbus, IN provides stock splitting risk mitigation services and will offer additional cGMP offerings in 2026.
Eurofins Central Laboratory provides comprehensive safety, efficacy, biomarker, and pathology services through a global network of CAP-accredited laboratories, supporting clinical trials in more than 85 countries. Globally Harmonized, Personalized Partnership: We deliver the best of both worlds - you gain a trusted ally committed to your success.
